Effectdossier · gearchiveerd kwartaal
CAPR
Capricor Therapeutics, Inc. · Healthcare · Biotechnology
17Gevolgde houders
+3Δ houders
9.08MGehouden aandelen
$65.46MGerapporteerde waarde
+3Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +21.4% ·
aandelenstroom -3.6% ·
netto nieuwe posities +17.6%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 70 | -1 | 21.29M | $513.07M | +4 | −5 |
| Q1 2026 | 74 | +11 | 17.90M | $543.13M | +17 | −6 |
| Q4 2025 | 63 | 0 | 16.01M | $462.15M | +1 | −1 |
| Q3 2025 | 17 | +3 | 9.08M | $65.46M | +3 | — |
| Q2 2025 | 11 | +1 | 8.31M | $82.57M | +2 | −1 |
| Q1 2025 | 7 | -3 | 3.63M | $34.48M | — | −3 |
| Q4 2024 | 10 | +4 | 3.77M | $51.99M | +5 | −1 |
| Q3 2024 | 5 | -1 | 1.06M | $16.12M | +2 | −3 |
| Q2 2024 | 6 | — | 1.44M | $6.86M | — | — |
Wie het bezit · Q3 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 2.87M | -3.8% | $20.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 2.87M | -3.8% | $20.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 2.87M | -3.8% | $20.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 2.87M | -3.8% | $20.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 2.87M | -3.8% | $20.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 2.87M | -3.8% | $20.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 2.87M | -3.8% | $20.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | The Vanguard Group ✦ (passief) | 2.21M | -4.3% | $15.91M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | The Vanguard Group ✦ (passief) | 2.21M | -4.3% | $15.91M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passief) | 2.21M | -4.3% | $15.91M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passief) | 961.57K | -0.2% | $6.93M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passief) | 961.57K | -0.2% | $6.93M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | State Street Global Advisors ✦ (passief) | 801.34K | -45.4% | $5.78M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 551.69K | — | $3.98M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Morgan Stanley ✦ | 551.69K | — | $3.98M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 551.69K | — | $3.98M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 551.69K | — | $3.98M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 551.69K | — | $3.98M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 551.69K | — | $3.98M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 379.60K | — | $2.74M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 379.60K | — | $2.74M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 379.60K | — | $2.74M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 379.60K | — | $2.74M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 379.60K | — | $2.74M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 379.60K | — | $2.74M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 379.60K | — | $2.74M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 379.60K | — | $2.74M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Two Sigma Investments ✦ | 355.80K | +128.3% | $2.57M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 29 | Millennium Management ✦ | 202.46K | +16.5% | $1.46M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 30 | Goldman Sachs Group ✦ | 175.64K | — | $1.27M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Goldman Sachs Group ✦ | 175.64K | — | $1.27M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 150.52K | Nieuw | $1.09M | 0.0% | New | 1 | SEC ↗ |
| 33 | Citadel Advisors ✦ | 150.52K | Nieuw | $1.09M | 0.0% | New | 1 | SEC ↗ |
| 34 | Wellington Management ✦ | 132.31K | +0.3% | $953,992 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 35 | Wellington Management ✦ | 132.31K | +0.3% | $953,992 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 36 | Wellington Management ✦ | 132.31K | +0.3% | $953,992 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 37 | Point72 Asset Management ✦ | 118.59K | Nieuw | $855,042 | 0.0% | New | 1 | SEC ↗ |
| 38 | Marshall Wace ✦ | 99.11K | +23.6% | $714,604 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | Marshall Wace ✦ | 99.11K | +23.6% | $714,604 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 40 | Fidelity (FMR) ✦ | 23.69K | -2.1% | $170,801 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 41 | Fidelity (FMR) ✦ | 23.69K | -2.1% | $170,801 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 42 | T. Rowe Price ✦ | 20.57K | +8.2% | $149,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 43 | D. E. Shaw & Co. ✦ | 15.95K | +48.6% | $114,963 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 44 | AQR Capital Management ✦ | 12.36K | Nieuw | $89,123 | 0.0% | New | 1 | SEC ↗ |
| 45 | AQR Capital Management ✦ | 12.36K | Nieuw | $89,123 | 0.0% | New | 1 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 12.36K | Nieuw | $89,123 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Citadel Advisors | $1.09M | 0.0% |
| Citadel Advisors | $1.09M | 0.0% |
| Point72 Asset Management | $855,042 | 0.0% |
| AQR Capital Management | $89,123 | 0.0% |
| AQR Capital Management | $89,123 | 0.0% |
| AQR Capital Management | $89,123 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 176 houders, 33.48M aandelen, $1.02B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q3 2025 ·
Methodologie ·
Verkrijg dit via de API